BRUSSELS, Feb 1 (Reuters) - The following are mergers under review by the European Commission and a brief guide to the EU merger process:
-- German private equity group Droege International to take control of German technology company ALSO-Actebis (approved Feb. 1)
-- Japanese conglomerate Mitsui to acquire part of American car dealer Penske Automotive Group’s Italian subsidiary PAG Italy S.r.l. (approved Feb. 1)
-- Private equity firm Advent International to acquire U.S. specialty chemicals maker Cytec’s coating resin business (notified Dec. 21/deadline Feb. 6)
-- Japanese auto parts maker U-Shin to buy French car parts equipment maker Valeo’s car lock unit (notified Dec. 21/deadline Feb. 6)
-- German service company BayWa AG to acquire a 60 percent stake in German agricultural wholesaler and retailer Bohnhorst Agrarhandel (notified Dec. 21/deadline Feb. 6)
-- Japanese conglomerate Mitsui & Co Ltd and Russian steel producer Severstal to acquire joint control of Russian steel product maker Severstal-SSC-Vsevolozhsk, which is now soley controlled by Severstal (notified Jan. 3/deadline Feb. 7/simplified)
-- French financial group PAI Partners to take control of French industrial supplier Industrial Parts Holding (IPH)(notified Jan. 7/deadline Feb. 11)
-- Japanese camera maker Canon to acquire Belgian document recognition company Iris (notified Jan. 14/deadline Feb. 18)
-- Private equity firm Clayton Dubilier & Rice to acquire British consumer goods retailer B&M (notified Jan. 16/deadline Feb. 20/simplified)
-- Belgian state-owned investment company SFPI to acquire a controlling stake in Franco-Belgian bank Dexia (notified Jan. 18/deadline Feb. 22)
-- The Turkish subsidiary of German power utility E.ON to buy a 50 percent stake in Turkish power company Enerijsa, which will give it joint control with Turkey’s Haci Omer Sabanci Holdings group (notified Jan. 18/deadline Feb. 22/simplified)
-- Japanese engineering company IHI Corp to buy the remaining 49 percent of German car turbo charger maker IHI Charging Systems International it does not own from German car maker Daimler AG (notified Jan. 18/deadline Feb. 22/simplified)
-- Private equity firm CVC Capital Partners to buy data information provider Cerved Holding (notified Jan. 18/deadline Feb. 22/simplified)
-- Private equity firm Triton to acquire Finnish grocery chain Suomen Lahikauppa from IK Investment Partners (notified Jan. 21/deadline Feb. 25)
-- Drugmakers Bristol-Myers Squibb and AstraZeneca to acquire joint control of Amylin Pharmaceuticals (notified Jan. 28/deadline March 4/simplified)
-- Norwegian group Orkla to buy family-controlled foods group Rieber & Soen (notified Jan. 28/deadline March 4)
-- U.S. carmaker General Motors to buy some operations belonging to car financing services provider Ally Financial (notified Jan. 29/deadline March 5/simplified)
-- Irish aircraft leasing company Avolon and U.S. bank Wells Fargo to set up a joint venture to lease airplanes (notified Jan. 30/deadline March 6/simplified)
-- Ryanair to acquire Aer Lingus (notified July 24/deadline extended for the fourth time to March 6 from Feb. 27 after Ryanair offered more commitments)
-- U.S. communications company Syniverse Technologies to buy Luxembourg-based communications services company Mach (notified Nov. 16/deadline extended for the second time to May 30 from May 15 after the companies asked for more time)
The European Commission has 25 working days after a deal is filed for a first-stage review. It may extend that by 10 working days to 35 working days, to consider either a company’s proposed remedies or an EU member state’s request to handle the case.
Most mergers win approval but occasionally the Commission opens a detailed second-stage investigation for up to 90 additional working days, which it may extend to 105 working days.
Under the simplified procedure, the Commission announces the clearance of uncontroversial first-stage mergers without giving any reason for its decision. Cases may be reclassified as non-simplified -- that is, ordinary first-stage reviews -- until they are approved.